Depletion of EBV-infected cells in donor marrow by counterflow elutriation

T. G. Gross, Steven Heye Hinrichs, J. R. Davis, D. Mitchell, M. R. Bishop, J. E. Wagner

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Epstein-Barr virus (EBV)-associated posttransplantation lymphoproliferative disease (PTLD) is a well-recognized complication of T cell-depleted (TCD) allogeneic bone marrow transplantation (BMT). Certain methods of TCD, such as counterflow elutriation (CE), have not been associated with an increased incidence of PTLD. Since CE depletes B cells as well as T cells, the hypothesis that CE depletes donor marrow of EBV-infected cells was tested in this study. Marrow samples from 70 donors were assayed by qualitative and semi-quantitative polymerase chain reaction (PCR) amplification to detect EBV DNA in four cellular fractions produced by elutriation: a small cell fraction (F70), two intermediate-sized cell fractions (F110 and F140), and a large cell (hematopoietic precursor- enriched, lymphocyte-depleted) rotor-off (R/O) fraction. The distribution of B cells in elutriation fractions was 21% (F70), 59% (F110), 18% (F140), and 2% (R/O). Qualitatively, the frequency of EBV DNA detected in fractions was 49% (F70), 57% (F110), 73% (F140), and 44% (R/O). The relative concentration of EBV DNA in each fraction was determined by semiquantitative PCR. The mean number of EBV DNA copies per 150,000 cells was 0.57 (F70), 4.6 (F110), 5.7 (F140), and 0.61 (R/O). Relative EBV DNA load in each fraction was calculated by multiplying the mean concentration of EBV DNA per fraction and mean mononuclear cell content in each fraction. The relative distribution of EBV DNA was 0.5, 58, 40, and 1.5% in the F70, F110, F140, and R/O fractions, respectively. No correlation between the amount of EBV in the graft and development of PTLD could be made, because only one of the 70 recipients developed PTLD and this was following autologous hematopoietic recovery. Although these results demonstrate that the majority of EBV-infected cells in marrow are separated from the TCD graft by counterflow elutriation, further studies are required to differentiate the role of this phenomenon from that of other potential factors, such as the amount of T cell depletion and recovery of EBV immunity in the pathogenesis of PTLD after BMT.

Original languageEnglish (US)
Pages (from-to)395-399
Number of pages5
JournalExperimental Hematology
Volume26
Issue number5
StatePublished - May 13 1998

Fingerprint

Human Herpesvirus 4
Bone Marrow
DNA
T-Lymphocytes
Bone Marrow Transplantation
B-Lymphocytes
Transplants
Polymerase Chain Reaction
Homologous Transplantation
Immunity
Lymphocytes

Keywords

  • Elutriation
  • Epstein-Barr virus
  • Posttransplantation lymphoproliferative disease

ASJC Scopus subject areas

  • Molecular Biology
  • Hematology
  • Genetics
  • Cell Biology
  • Cancer Research

Cite this

Gross, T. G., Hinrichs, S. H., Davis, J. R., Mitchell, D., Bishop, M. R., & Wagner, J. E. (1998). Depletion of EBV-infected cells in donor marrow by counterflow elutriation. Experimental Hematology, 26(5), 395-399.

Depletion of EBV-infected cells in donor marrow by counterflow elutriation. / Gross, T. G.; Hinrichs, Steven Heye; Davis, J. R.; Mitchell, D.; Bishop, M. R.; Wagner, J. E.

In: Experimental Hematology, Vol. 26, No. 5, 13.05.1998, p. 395-399.

Research output: Contribution to journalArticle

Gross, TG, Hinrichs, SH, Davis, JR, Mitchell, D, Bishop, MR & Wagner, JE 1998, 'Depletion of EBV-infected cells in donor marrow by counterflow elutriation', Experimental Hematology, vol. 26, no. 5, pp. 395-399.
Gross TG, Hinrichs SH, Davis JR, Mitchell D, Bishop MR, Wagner JE. Depletion of EBV-infected cells in donor marrow by counterflow elutriation. Experimental Hematology. 1998 May 13;26(5):395-399.
Gross, T. G. ; Hinrichs, Steven Heye ; Davis, J. R. ; Mitchell, D. ; Bishop, M. R. ; Wagner, J. E. / Depletion of EBV-infected cells in donor marrow by counterflow elutriation. In: Experimental Hematology. 1998 ; Vol. 26, No. 5. pp. 395-399.
@article{505b602a173840e28bccc42ad5fa7297,
title = "Depletion of EBV-infected cells in donor marrow by counterflow elutriation",
abstract = "Epstein-Barr virus (EBV)-associated posttransplantation lymphoproliferative disease (PTLD) is a well-recognized complication of T cell-depleted (TCD) allogeneic bone marrow transplantation (BMT). Certain methods of TCD, such as counterflow elutriation (CE), have not been associated with an increased incidence of PTLD. Since CE depletes B cells as well as T cells, the hypothesis that CE depletes donor marrow of EBV-infected cells was tested in this study. Marrow samples from 70 donors were assayed by qualitative and semi-quantitative polymerase chain reaction (PCR) amplification to detect EBV DNA in four cellular fractions produced by elutriation: a small cell fraction (F70), two intermediate-sized cell fractions (F110 and F140), and a large cell (hematopoietic precursor- enriched, lymphocyte-depleted) rotor-off (R/O) fraction. The distribution of B cells in elutriation fractions was 21{\%} (F70), 59{\%} (F110), 18{\%} (F140), and 2{\%} (R/O). Qualitatively, the frequency of EBV DNA detected in fractions was 49{\%} (F70), 57{\%} (F110), 73{\%} (F140), and 44{\%} (R/O). The relative concentration of EBV DNA in each fraction was determined by semiquantitative PCR. The mean number of EBV DNA copies per 150,000 cells was 0.57 (F70), 4.6 (F110), 5.7 (F140), and 0.61 (R/O). Relative EBV DNA load in each fraction was calculated by multiplying the mean concentration of EBV DNA per fraction and mean mononuclear cell content in each fraction. The relative distribution of EBV DNA was 0.5, 58, 40, and 1.5{\%} in the F70, F110, F140, and R/O fractions, respectively. No correlation between the amount of EBV in the graft and development of PTLD could be made, because only one of the 70 recipients developed PTLD and this was following autologous hematopoietic recovery. Although these results demonstrate that the majority of EBV-infected cells in marrow are separated from the TCD graft by counterflow elutriation, further studies are required to differentiate the role of this phenomenon from that of other potential factors, such as the amount of T cell depletion and recovery of EBV immunity in the pathogenesis of PTLD after BMT.",
keywords = "Elutriation, Epstein-Barr virus, Posttransplantation lymphoproliferative disease",
author = "Gross, {T. G.} and Hinrichs, {Steven Heye} and Davis, {J. R.} and D. Mitchell and Bishop, {M. R.} and Wagner, {J. E.}",
year = "1998",
month = "5",
day = "13",
language = "English (US)",
volume = "26",
pages = "395--399",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Depletion of EBV-infected cells in donor marrow by counterflow elutriation

AU - Gross, T. G.

AU - Hinrichs, Steven Heye

AU - Davis, J. R.

AU - Mitchell, D.

AU - Bishop, M. R.

AU - Wagner, J. E.

PY - 1998/5/13

Y1 - 1998/5/13

N2 - Epstein-Barr virus (EBV)-associated posttransplantation lymphoproliferative disease (PTLD) is a well-recognized complication of T cell-depleted (TCD) allogeneic bone marrow transplantation (BMT). Certain methods of TCD, such as counterflow elutriation (CE), have not been associated with an increased incidence of PTLD. Since CE depletes B cells as well as T cells, the hypothesis that CE depletes donor marrow of EBV-infected cells was tested in this study. Marrow samples from 70 donors were assayed by qualitative and semi-quantitative polymerase chain reaction (PCR) amplification to detect EBV DNA in four cellular fractions produced by elutriation: a small cell fraction (F70), two intermediate-sized cell fractions (F110 and F140), and a large cell (hematopoietic precursor- enriched, lymphocyte-depleted) rotor-off (R/O) fraction. The distribution of B cells in elutriation fractions was 21% (F70), 59% (F110), 18% (F140), and 2% (R/O). Qualitatively, the frequency of EBV DNA detected in fractions was 49% (F70), 57% (F110), 73% (F140), and 44% (R/O). The relative concentration of EBV DNA in each fraction was determined by semiquantitative PCR. The mean number of EBV DNA copies per 150,000 cells was 0.57 (F70), 4.6 (F110), 5.7 (F140), and 0.61 (R/O). Relative EBV DNA load in each fraction was calculated by multiplying the mean concentration of EBV DNA per fraction and mean mononuclear cell content in each fraction. The relative distribution of EBV DNA was 0.5, 58, 40, and 1.5% in the F70, F110, F140, and R/O fractions, respectively. No correlation between the amount of EBV in the graft and development of PTLD could be made, because only one of the 70 recipients developed PTLD and this was following autologous hematopoietic recovery. Although these results demonstrate that the majority of EBV-infected cells in marrow are separated from the TCD graft by counterflow elutriation, further studies are required to differentiate the role of this phenomenon from that of other potential factors, such as the amount of T cell depletion and recovery of EBV immunity in the pathogenesis of PTLD after BMT.

AB - Epstein-Barr virus (EBV)-associated posttransplantation lymphoproliferative disease (PTLD) is a well-recognized complication of T cell-depleted (TCD) allogeneic bone marrow transplantation (BMT). Certain methods of TCD, such as counterflow elutriation (CE), have not been associated with an increased incidence of PTLD. Since CE depletes B cells as well as T cells, the hypothesis that CE depletes donor marrow of EBV-infected cells was tested in this study. Marrow samples from 70 donors were assayed by qualitative and semi-quantitative polymerase chain reaction (PCR) amplification to detect EBV DNA in four cellular fractions produced by elutriation: a small cell fraction (F70), two intermediate-sized cell fractions (F110 and F140), and a large cell (hematopoietic precursor- enriched, lymphocyte-depleted) rotor-off (R/O) fraction. The distribution of B cells in elutriation fractions was 21% (F70), 59% (F110), 18% (F140), and 2% (R/O). Qualitatively, the frequency of EBV DNA detected in fractions was 49% (F70), 57% (F110), 73% (F140), and 44% (R/O). The relative concentration of EBV DNA in each fraction was determined by semiquantitative PCR. The mean number of EBV DNA copies per 150,000 cells was 0.57 (F70), 4.6 (F110), 5.7 (F140), and 0.61 (R/O). Relative EBV DNA load in each fraction was calculated by multiplying the mean concentration of EBV DNA per fraction and mean mononuclear cell content in each fraction. The relative distribution of EBV DNA was 0.5, 58, 40, and 1.5% in the F70, F110, F140, and R/O fractions, respectively. No correlation between the amount of EBV in the graft and development of PTLD could be made, because only one of the 70 recipients developed PTLD and this was following autologous hematopoietic recovery. Although these results demonstrate that the majority of EBV-infected cells in marrow are separated from the TCD graft by counterflow elutriation, further studies are required to differentiate the role of this phenomenon from that of other potential factors, such as the amount of T cell depletion and recovery of EBV immunity in the pathogenesis of PTLD after BMT.

KW - Elutriation

KW - Epstein-Barr virus

KW - Posttransplantation lymphoproliferative disease

UR - http://www.scopus.com/inward/record.url?scp=0031981397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031981397&partnerID=8YFLogxK

M3 - Article

C2 - 9590655

AN - SCOPUS:0031981397

VL - 26

SP - 395

EP - 399

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 5

ER -